Drugs / Magnesiocard
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07149649 | Aug 2026 → Jan 2031 expected | non-small cell lung carcinoma | Swiss Cancer Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesiocard | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07149649 ↗ |
| Route | Oral | “peroral thrice daily (day 1-21)” NCT07149649 ↗ |